References
- Hekimian G, Kharcha F, Bréchot N, Schmidt M, Ghander C, Lebreton G,
Girerd X, Tresallet C, Trouillet JL, Leprince P, Chastre J, Combes A,
Luyt CE. Extracorporeal membrane oxygenation for
pheochromocytoma-induced cardiogenic shock. Ann. Intensive Care2016; 6:117.
- Simons M, Downing SE. Coronary vasoconstriction and catecholamine
cardiomyopathy. Am Heart J 1985; 109(2):297–304.
- Opie LH, Walpoth B, Barsacchi R. Calcium and catecholamines: relevance
to cardiomyopathies and significance in therapeutic strategies.J Mol Cell Cardiol 1985; 17(Suppl 2):21–34.
- Costa VM, Carvalho F, Bastos ML, Carvalho RA, Carvalho M, Remião F.
Contribution of catecholamine reactive intermediates and oxidative
stress to the pathologic features of heart diseases. Curr Med
Chem 2011;18(15):2272–314.
- Rosenbaum JS, Billingham ME, Ginsburg R, Tsujimoto G, Lurie KG,
Hoffman BB. Cardiomyopathy in a rat model of pheochromocytoma.
Morphological and functional alterations. Am J Cardiovasc
Pathol 1988;1(3):389–99.
- Tschöpe C, Van Linthout S, Klein O, Mairinger T, Krackhardt F, Potapov
EV, Schmidt G, Burkhoff D, Pieske B, Spillmann F. Mechanical Unloading
by Fulminant Myocarditis: LV-IMPELLA, ECMELLA, BI-PELLA,and PROPELLA
Concepts. J Cardiovasc Transl Res 2019; 12:116–123.
- Hekimian G, Kharcha F, Bréchot N, Schmidt M, Ghander C, Lebreton G,
Girerd X, Tresallet C, Trouillet JL, Leprince P, Chastre J, Combes A
and Luyt CE. Extracorporeal membrane oxygenation for
pheochromocytoma-induced cardiogenic shock. Ann. Intensive Care2016; 6:117.
- Riester A, Weismann D, Quinkler M, Lichtenauer UD, Sommerey S,
Halbritter R, Penning R, Spitzweg C, Schopohl J, Beuschlein F, Reincke
M. Life‐threatening events in patients with pheochromocytoma.Eur J Endocrinol 2015; 173(6):757–64.